Boc-D-cysteine
Need Assistance?
  • US & Canada:
    +
  • UK: +

Boc-D-cysteine

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Boc-D-cysteine is an N-Boc-protected form of D-Cysteine. D-Cysteine is a strong inhibitor of Escherichia coli growth and also functions to provide inorganic sulfates for the sulfation of xenobiotics. D-Cysteine is a non-physiological isomer of L-Cysteine, and is not involved in protein or glutathione synthesis.

Category
BOC-Amino Acids
Catalog number
BAT-007634
CAS number
149270-12-2
Molecular Formula
C8H15NO4S
Molecular Weight
221.30
Boc-D-cysteine
IUPAC Name
(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-sulfanylpropanoic acid
Synonyms
Boc-D-Cys-OH; N-Boc-D-cysteine; Boc-D-cysteine; (S)-2-((tert-Butoxycarbonyl)amino)-3-mercaptopropanoic acid; D-Cysteine, N-[(1,1-dimethylethoxy)carbonyl]-; (tert-Butoxycarbonyl)-D-cysteine; Boc-D-Cys-OH; (2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-sulfanylpropanoic acid; AmbotzBAA1170; N-[(1,1-dimethylethoxy)carbonyl]-D-cysteine; Boc D Cys OH
Appearance
White crystalline powder
Purity
≥ 99% (Assay by titration)
Melting Point
71-79 °C
Storage
Store at 2-8 °C
InChI
InChI=1S/C8H15NO4S/c1-8(2,3)13-7(12)9-5(4-14)6(10)11/h5,14H,4H2,1-3H3,(H,9,12)(H,10,11)/t5-/m1/s1
InChI Key
ATVFTGTXIUDKIZ-RXMQYKEDSA-N
Canonical SMILES
CC(C)(C)OC(=O)NC(CS)C(=O)O

Boc-D-cysteine, a protected amino acid of significance in peptide synthesis and pharmaceutical exploration, is a versatile reagent with diverse applications. Here are four key applications:

Peptide Synthesis: Integral to peptide synthesis, Boc-D-cysteine plays a crucial role in crafting peptides, where the Boc (tert-butyloxycarbonyl) shielding group safeguards the cysteine amino moiety. This protective measure enables selective deprotection and coupling in solid-phase peptide synthesis, ensuring the precise integration of cysteine residues into peptides. This intricate process facilitates the production of intricate therapeutic peptides and proteins.

Pharmaceutical Research: At the frontier of pharmaceutical innovation, Boc-D-cysteine emerges as a pivotal intermediate in the formulation of peptide-driven drugs. Pharmaceutical pioneers leverage its capabilities to fashion peptides endowed with specific structural attributes, tailored to combat diseases like cancer or autoimmune disorders. By shielding the cysteine residue, unwanted side reactions are averted, culminating in heightened yield and purity of the final therapeutic concoction.

Bioconjugation: Positioned at the intersection of biochemistry and pharmaceuticals, Boc-D-cysteine assumes a pivotal role in bioconjugation processes aimed at fusing biologically active molecules with peptides or proteins. The thiol group of cysteine engenders stable bonds with diverse functional groups, rendering it ideal for the creation of conjugates with drugs, dyes, or polymers. This intricate fusion is at the heart of developing targeted drug delivery systems and cutting-edge diagnostic tools, revolutionizing the landscape of personalized medicine.

Enzyme Engineering: In the realm of enzyme manipulation and optimization, Boc-D-cysteine emerges as a potent tool for incorporating into enzyme active sites during protein engineering endeavors. Through the selective introduction of cysteine residues, scientists can finely tune enzyme functions, stability, and substrate specificity. This sophisticated technique underpins the creation of enzymes with heightened performance metrics, tailored for diverse industrial biotechnology applications spanning biofuels, pharmaceuticals, and fine chemical synthesis, reshaping the horizon of enzymatic catalysis.

1. Investigation of the coordination interactions of S-(pyridin-2-ylmethyl)-L-cysteine ligands with M(CO)(3)(+) (M = Re, (99m)Tc)
Haiyang He, Jennifer E Morley, Brendan Twamley, Ryan H Groeneman, Dejan-Kresimir Bucar, Leonard R MacGillivray, Paul D Benny Inorg Chem. 2009 Nov 16;48(22):10625-34. doi: 10.1021/ic901159r.
Development of new ligands for fac-M(OH(2))(3)(CO)(3)(+) (M = Re, (99m)Tc) led the investigation with S-(pyridin-2-ylmethyl)-l-cysteine, 1. The ligand 1 has potential to coordinate with the metal through three different tridentate modes: tripodal through cysteine (O,N,S) and two linear involving the S-pyridyl and cysteine (O,S,N(Py), N,S,N(Py)). From the reaction with 1, two species were observed in the (1)H NMR, where the primary product was the linear fac-Re(N,S,N(Py)-1)(CO)(3)(+), 2a, complex. To identify the coordination mode of the minor product, functionalized analogues of 1 were prepared from S-(pyridin-2-ylmethyl)-Boc-l-cysteine-methyl ester, 3, with orthogonal protecting groups on the C terminus (methyl ester) in S-(pyridin-2-ylmethyl)-l-cysteine methyl ester, 4, or N terminus (Boc) in S-(pyridin-2-ylmethyl)-Boc-l-cysteine, 6, that specifically directed the coordination mode of fac-M(H(2)O)(3)(CO)(3)(+) to either N,S,N(Py) or O,S,N(Py), respectively. Two diastereomers [fac-Re(CO)(3)(N,S,N(Py)-4)](+), 5a and 5b, were observed and independently characterized by X-ray structure analysis and NMR in high yield with 4. Surprisingly, the O,S,N(Py) Re complex with ligand 6 was not observed and simplified versions, 3-(pyridin-2-ylmethylthio) propanoic acid, 7, and 2-(pyridin-2-ylmethylthio)acetic acid, 8, were investigated. Ligand 7 did not yield the desired linear tridentate O,S,N(Py) product. However, the shorter ligand 8 formed fac-Re(CO)(3)(O,S,N(Py)-8), 9, in high yield. (99m)Tc labeling studies were conducted and yielded similar results to the rhenium complex and effective (>99%) at 10(-5) M ligand concentration.
2. Half-sandwich complexes of iridium and ruthenium containing cysteine-derived ligands
María Carmona, Ricardo Rodríguez, Fernando J Lahoz, Pilar García-Orduña, Carlos Cativiela, José A López, Daniel Carmona Dalton Trans. 2017 Jan 17;46(3):962-976. doi: 10.1039/c6dt04341k.
The dimers [{(ηn-ring)MCl}2(μ-Cl)2] ((ηn-ring)M = (η5-C5Me5)Ir, (η6-p-MeC6H4iPr)Ru) react with the modified cysteines S-benzyl-l-cysteine (HL1) or S-benzyl-α-methyl-l-cysteine (HL2) affording cationic complexes of the formula [(ηn-ring)MCl(κ2N,S-HL)]Cl (1, 2) in good yield. Addition of NaHCO3 to complexes 1 and 2 gave equilibrium mixtures of neutral [(ηn-ring)MCl(κ2N,O-L)] (3, 4) and cationic [(ηn-ring)M(κ3N,O,S-L)]Cl (6Cl, 7Cl) complexes. Similar mixtures were obtained in one-pot reaction by successive addition of the modified cysteine and NaHCO3 to the above formulated dimers. Addition of the N-Boc substituted cysteine derivative S-benzyl-N-Boc-l-cysteine (HL3) and NaHCO3 to the dimers [{(ηn-ring)MCl}2(μ-Cl)2] affords the neutral compounds [(ηn-ring)MCl(κ2O,S-L3)] ((ηn-ring)M = (η5-C5Me5)Ir (5a), (η6-p-MeC6H4iPr)Ru (5b)). Complexes of the formula [(ηn-ring)MCl(κ3N,O,S-L)][SbF6] (6Sb-8Sb), in which the cysteine derivative acts as a tridentate chelate ligand, can be prepared by adding one equivalent of AgSbF6 to the solutions of compounds 5 or to the mixtures of complexes 3/6Cl and 4/7Cl. The amide proton of compounds 8aSb and 8bSb can be removed by addition of NaHCO3 affording the neutral complexes [(ηn-ring)M(κ3N,O,S-L3-H)] ((ηn-ring)M = (η5-C5Me5)Ir (9a), (η6-p-MeC6H4iPr)Ru (9b)). Complexes 9a and 9b can also be prepared by reacting the dimers [{(ηn-ring)MCl}2(μ-Cl)2] with HL3 and two equivalents of NaHCO3. The absolute configuration of the complexes has been established by spectroscopic and diffractometric means including the crystal structure determination of (RIr,RC,RS)-[(η5-C5Me5)Ir(κ3N,O,S-L1)][SbF6] (6aSb). The thermodynamic parameters associated with the epimerization at sulphur that the iridium compound [(η5-C5Me5)Ir(κ3N,O,S-L3-H)] (9a) undergoes have been determined through variable temperature 1H NMR studies.
3. Thiol-Mediated Controlled Ring-Opening Polymerization of Cysteine-Derived β-Thiolactone and Unique Features of Product Polythioester
Masato Suzuki, Kazumasa Makimura, Shin-ichi Matsuoka Biomacromolecules. 2016 Mar 14;17(3):1135-41. doi: 10.1021/acs.biomac.5b01748. Epub 2016 Feb 25.
The controlled ring-opening polymerization of the β-thiolactone derived from N-Boc cysteine was achieved using N-Boc-L-cysteine methyl ester as the initiator in NMP at room temperature. The propagating end is the thiol group, which attacks the carbonyl to open the monomer ring by the C(═O)-S bond scission. A thiol-ene click reaction demonstrated the utility of the thiol group at the propagating terminal. The block copolymer was efficiently produced by the terminal coupling of the polythioester with the norbornene terminated PEG. As another interesting reaction, the polythioester underwent the main chain transformation to polycysteine through the intramolecular S-to-N acyl migration, triggered by the deprotection of the pendant Boc groups. The polythioester from L-cysteine showed Cotton effects between 200 and 300 nm in the circular dichroism (CD) spectrum. Although the CD pattern resembled that produced by the α-helix of polypeptide, it was ascribable not to the second structure but to the relative orientation of the thioester and carbamate carbonyls in the repeating unit.
Online Inquiry
Verification code
Inquiry Basket